A study Of checkpoint inhibitors in patients with radiologic or histological evidence of bile duct injury : a case series
Latest Information Update: 17 Aug 2021
At a glance
- Drugs Atezolizumab (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Chemotherapy-induced damage
- Focus Adverse reactions
Most Recent Events
- 17 Aug 2021 New trial record
- 26 Jun 2021 Results presented at The International Liver Congress 2021